These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34210121)

  • 41. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
    Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
    Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delay in ICR/f rat lens opacification by the instillation of eye drops containing disulfiram and hydroxypropyl-beta-cyclodextrin inclusion complex.
    Nagai N; Takeda M; Ito Y; Takeuchi N; Kamei A
    Biol Pharm Bull; 2007 Aug; 30(8):1529-34. PubMed ID: 17666815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate.
    Miro A; Quaglia F; Giannini L; Cappello B; La Rotonda MI
    Curr Drug Deliv; 2006 Oct; 3(4):373-8. PubMed ID: 17076639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
    Tirucherai GS; Mitra AK
    AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin complexation with hydroxypropyl-beta-cyclodextrin: Spectroscopic evaluation of molecular inclusion and use of the complex in gel for healing of pressure ulcers.
    Valentini SR; Nogueira AC; Fenelon VC; Sato F; Medina AN; Santana RG; Baesso ML; Matioli G
    Int J Pharm; 2015 Jul; 490(1-2):229-39. PubMed ID: 25987212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between a novel gemini surfactant and cyclodextrin: NMR and surface tension studies.
    Abrahmsén-Alami S; Alami E; Eastoe J; Cosgrove T
    J Colloid Interface Sci; 2002 Feb; 246(1):191-202. PubMed ID: 16290400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient.
    Ponce-Ponte M; Aloisio C; Romero-Guerra DM; Gracia-Vásquez S; Garnero C; Longhi M
    Ther Deliv; 2018 Sep; 9(9):639-652. PubMed ID: 30189811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inclusional complex study between 6-p-toluidinylnaphthalene-2-sulfonate and 2-hydroxypropyl-beta-cyclodextrin.
    Dotsikas Y; Loukas YL
    J Biochem Biophys Methods; 2002 Jul; 52(2):121-34. PubMed ID: 12204416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions.
    Prajapati M; Eiriksson FF; Loftsson T
    Int J Pharm; 2020 Aug; 586():119579. PubMed ID: 32599134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time-dependent loss of radioactivity counts associated with paracellular markers in the presence of cyclodextrin.
    Pezron I; Tirucherai GS; Mitra AK
    Int J Pharm; 2002 Jan; 231(2):237-40. PubMed ID: 11755275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of solubilization and complexation characteristics for new antifungal compound with cyclodextrins. Impact of cyclodextrins on distribution process.
    Volkova TV; Perlovich GL
    Eur J Pharm Sci; 2020 Nov; 154():105531. PubMed ID: 32871213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
    Lilletvedt M; Kristensen S; Tønnesen HH
    Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-beta-cyclodextrin.
    Yamakawa T; Nishimura S
    J Control Release; 2003 Jan; 86(1):101-13. PubMed ID: 12490376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.
    Zhang H; Chen M; He Z; Wang Z; Zhang M; He Z; Wan Q; Liang D; Repka MA; Wu C
    AAPS PharmSciTech; 2013 Mar; 14(1):10-8. PubMed ID: 23160918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by hydroxypropyl-beta-cyclodextrin, or methyl-beta-cyclodextrin in water.
    He Y; Yalkowsky SH
    J Hazard Mater; 2004 Apr; 108(1-2):129-31. PubMed ID: 15081172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.